Filtered By:
Source: Journal of Drugs in Dermatology
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 922 results found since Jan 2013.
A Review of Antithrombotic Agents in Dermatologic Surgery and Context for a Practical Approach, With Cardiology and Pharmacologic Input
J Drugs Dermatol. 2023 May 1;22(5):496-501. doi: 10.36849/JDD.7456.ABSTRACTDermatologic surgeons are encountering more patients on antithrombotic agents. There are no established consensus guidelines for managing antithrombotic agents in the perioperative period. We provide an updated overview of antithrombotic agents in dermatologic surgery and management of such agents in the perioperative period with additional unique perspectives from cardiology and pharmacy. A literature search of PubMed and Google Scholar was performed to review the English-language medical literature. The landscape of antithrombotic therapy is chang...
Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Elizabeth Rao Wyatt Andrasik Basia Michalski Khaldoun Tarakji Michael Militello Jennifer Lucas Source Type: research
Allergens in Common Brands of Clobetasol
CONCLUSIONS: Forty-nine different ingredients were identified among all 18 products included, with an average of 8.4 ingredients per product; 19 of these ingredients have allergenic potential, while one has protective effects. Two branded foam formulations contained the greatest number of potential allergens (5), while a shampoo formulation contained no potential allergens. Knowing which allergens are present in different products may be helpful when treating a patient with an allergy or suspected allergy to one of these ingredients. J Drugs Dermatol. 2023;22(5): doi:10.36849/JDD.4651.PMID:37133477 | DOI:10.36849/JDD.4651
Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Leena Ramani Wasim Haidari Shalanda Hall Sima Amin Sarah Chisolm Steven Feldman Source Type: research
The Role of Skin Substitutes in Dermatologic Surgery: A Practical Review
CONCLUSION: Considerations of the characteristics, settings of use, and efficacies of SS may allow more effective wound care and the potential for faster healing times. Additional studies are needed to evaluate and compare the healing benefits of these substitutes. Trials comparing the efficacy of each of the common SS vs each other and granulation are needed. J Drugs Dermatol. 2023;22(5): doi:10.36849/JDD.7132.PMID:37133470 | DOI:10.36849/JDD.7132
Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Mitchell Davis Katelyn Dugan Brett Neill Melissa Shive Stanislav Tolkachjov Source Type: research
Anti-Tumor Necrosis Factor Alpha Therapeutic Drug Monitoring in Inflammatory Disease: A Systematic Review
CONCLUSION: TDM of anti-TNF-α biologics in IBD has demonstrated success through RCTs. Knowledge gained from these studies applies to dermatologic treatment. J Drugs Dermatol. 2023;22(5): doi:10.36849/JDD.6671.PMID:37133467 | DOI:10.36849/JDD.6671
Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Caralin Schneider Scott Stratman Siri Choragudi Hadar Lev-Tov Source Type: research
A Review of Antithrombotic Agents in Dermatologic Surgery and Context for a Practical Approach, With Cardiology and Pharmacologic Input
J Drugs Dermatol. 2023 May 1;22(5):496-501. doi: 10.36849/JDD.7456.ABSTRACTDermatologic surgeons are encountering more patients on antithrombotic agents. There are no established consensus guidelines for managing antithrombotic agents in the perioperative period. We provide an updated overview of antithrombotic agents in dermatologic surgery and management of such agents in the perioperative period with additional unique perspectives from cardiology and pharmacy. A literature search of PubMed and Google Scholar was performed to review the English-language medical literature. The landscape of antithrombotic therapy is chang...
Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Elizabeth Rao Wyatt Andrasik Basia Michalski Khaldoun Tarakji Michael Militello Jennifer Lucas Source Type: research
Allergens in Common Brands of Clobetasol
CONCLUSIONS: Forty-nine different ingredients were identified among all 18 products included, with an average of 8.4 ingredients per product; 19 of these ingredients have allergenic potential, while one has protective effects. Two branded foam formulations contained the greatest number of potential allergens (5), while a shampoo formulation contained no potential allergens. Knowing which allergens are present in different products may be helpful when treating a patient with an allergy or suspected allergy to one of these ingredients. J Drugs Dermatol. 2023;22(5): doi:10.36849/JDD.4651.PMID:37133477 | DOI:10.36849/JDD.4651
Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Leena Ramani Wasim Haidari Shalanda Hall Sima Amin Sarah Chisolm Steven Feldman Source Type: research
The Role of Skin Substitutes in Dermatologic Surgery: A Practical Review
CONCLUSION: Considerations of the characteristics, settings of use, and efficacies of SS may allow more effective wound care and the potential for faster healing times. Additional studies are needed to evaluate and compare the healing benefits of these substitutes. Trials comparing the efficacy of each of the common SS vs each other and granulation are needed. J Drugs Dermatol. 2023;22(5): doi:10.36849/JDD.7132.PMID:37133470 | DOI:10.36849/JDD.7132
Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Mitchell Davis Katelyn Dugan Brett Neill Melissa Shive Stanislav Tolkachjov Source Type: research
Anti-Tumor Necrosis Factor Alpha Therapeutic Drug Monitoring in Inflammatory Disease: A Systematic Review
CONCLUSION: TDM of anti-TNF-α biologics in IBD has demonstrated success through RCTs. Knowledge gained from these studies applies to dermatologic treatment. J Drugs Dermatol. 2023;22(5): doi:10.36849/JDD.6671.PMID:37133467 | DOI:10.36849/JDD.6671
Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Caralin Schneider Scott Stratman Siri Choragudi Hadar Lev-Tov Source Type: research
The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
CONCLUSIONS: Existing and emerging therapeutic biologics targeting the IL-23/IL-17 pathway are promising options to treat IMIDs while the knowledge of the pathophysiology of those conditions and the contribution of the IL23/IL-17 continues to grow. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7017 Citation: Galli Sanchez AP, Castanheiro da Costa A, Del Rey C, et al. The overview of the immunobiology of interleukin-23 associated with immune-mediated inflammatory disorders. A narrative review. J Drugs Dermatol. 2023;22(4):375-385. doi:10.36849/JDD.7017.PMID:37026890 | DOI:10.36849/JDD.7017
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Ana Paula Sanchez Andreia da Costa Cintia Del Rey Bruno Silva Ricardo Romiti Source Type: research
Update on Hormonal Therapy in Hidradenitis Suppurativa
J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235.ABSTRACTHidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a profound impact on quality of life. In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of HS, including finasteride, cyproterone acetate, spironolactone, oral contraceptive pills, and metformin. A detailed search was conducted on these databases using key words like ‘hidradeniti...
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Priyanka Karagaiah Steven Daveluy Alex Ortega-Loayza Wayne Gulliver Jacek Szepietowski Stephan Grabbe Mohamad Goldust Source Type: research
The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
CONCLUSIONS: Existing and emerging therapeutic biologics targeting the IL-23/IL-17 pathway are promising options to treat IMIDs while the knowledge of the pathophysiology of those conditions and the contribution of the IL23/IL-17 continues to grow. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7017 Citation: Galli Sanchez AP, Castanheiro da Costa A, Del Rey C, et al. The overview of the immunobiology of interleukin-23 associated with immune-mediated inflammatory disorders. A narrative review. J Drugs Dermatol. 2023;22(4):375-385. doi:10.36849/JDD.7017.PMID:37026890 | DOI:10.36849/JDD.7017
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Ana Paula Sanchez Andreia da Costa Cintia Del Rey Bruno Silva Ricardo Romiti Source Type: research
Update on Hormonal Therapy in Hidradenitis Suppurativa
J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235.ABSTRACTHidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a profound impact on quality of life. In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of HS, including finasteride, cyproterone acetate, spironolactone, oral contraceptive pills, and metformin. A detailed search was conducted on these databases using key words like ‘hidradeniti...
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Priyanka Karagaiah Steven Daveluy Alex Ortega-Loayza Wayne Gulliver Jacek Szepietowski Stephan Grabbe Mohamad Goldust Source Type: research
The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
CONCLUSIONS: Existing and emerging therapeutic biologics targeting the IL-23/IL-17 pathway are promising options to treat IMIDs while the knowledge of the pathophysiology of those conditions and the contribution of the IL23/IL-17 continues to grow. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7017 Citation: Galli Sanchez AP, Castanheiro da Costa A, Del Rey C, et al. The overview of the immunobiology of interleukin-23 associated with immune-mediated inflammatory disorders. A narrative review. J Drugs Dermatol. 2023;22(4):375-385. doi:10.36849/JDD.7017.PMID:37026890 | DOI:10.36849/JDD.7017
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Ana Paula Sanchez Andreia da Costa Cintia Del Rey Bruno Silva Ricardo Romiti Source Type: research
Update on Hormonal Therapy in Hidradenitis Suppurativa
J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235.ABSTRACTHidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a profound impact on quality of life. In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of HS, including finasteride, cyproterone acetate, spironolactone, oral contraceptive pills, and metformin. A detailed search was conducted on these databases using key words like ‘hidradeniti...
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Priyanka Karagaiah Steven Daveluy Alex Ortega-Loayza Wayne Gulliver Jacek Szepietowski Stephan Grabbe Mohamad Goldust Source Type: research
